SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000886163-13-000004
Filing Date
2013-01-11
Accepted
2013-01-11 14:45:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G ligand-retrophin13g.htm SC 13G 53124
  Complete submission text file 0000886163-13-000004.txt   54680
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filed by) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 414 SE WASHINGTON 102 BARTLESVILLE OK 74006
Business Address 414 SE WASHINGTON 102 BARTLESVILLE OK 74006 918-336-1773
Desert Gateway, Inc. (Subject) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: OK | Fiscal Year End: 0229
Type: SC 13G | Act: 34 | File No.: 005-87088 | Film No.: 13525202
SIC: 6770 Blank Checks